Bluejay Diagnostics (BJDX) Shares Outstanding (Entity) (2020 - 2026)
Bluejay Diagnostics (BJDX) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 1.73 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 383.57 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 576.60 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 377.40 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 451.69 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 977.43 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 97.50 Mn |
| 10 | Bluejay Diagnostics | 1.93 Mn | 1.93 Mn | - | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.08 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 449,043.00 |
| Sep 30, 2025 | 409,783.00 |
| Jun 30, 2025 | 373,546.00 |
| Mar 31, 2025 | 138,503.00 |
| Dec 31, 2024 | 45,848.00 |
| Sep 30, 2024 | 47,779.00 |
| Jun 30, 2024 | 2,416.00 |
| Mar 31, 2024 | 1,680.00 |
| Dec 31, 2023 | 774.00 |
| Sep 30, 2023 | 774.00 |
| Jun 30, 2023 | 640.00 |
| Mar 31, 2023 | 639.00 |
| Dec 31, 2022 | 632.00 |
| Sep 30, 2022 | 630.00 |
| Jun 30, 2022 | 630.00 |
| Mar 31, 2022 | 630.00 |
| Dec 31, 2021 | 266.00 |
| Sep 30, 2021 | 329.00 |